Hospice symptom management

Hospice pain management

Pain is the most reported symptom in hospice — and the most modifiable. Effective hospice pain management combines around-the-clock long-acting opioid coverage, breakthrough dosing at 10–20% of the 24-hour equivalent, and non-pharmacological adjuncts that respect the patient’s goals.

By Goodwin Hospice Academy Editorial Team·Published February 16, 2026

Educational content only. Individual clinicians must confirm current dosing and drug availability against their hospice medical director and current formulary. This is not a substitute for your hospice’s policies or your medical director’s clinical judgment.

Quick framework

Use the WHO Analgesic Ladder as a starting scaffold (mild → non-opioid; moderate → weak opioid or low-dose strong opioid; severe → titrate strong opioid).
Around-the-clock long-acting + as-needed short-acting for breakthrough.
Titrate at 25–50% dose increases every 24 hours for moderate–severe uncontrolled pain.
Reassess pain within 30–60 minutes of PRN dose (oral) or 15 minutes (parenteral).
Consider adjuvants (gabapentinoids, corticosteroids, low-dose antidepressants) for neuropathic or bone-metastatic pain.

Pharmacology

01Morphine remains the first-line strong opioid in most hospice formularies for oral use. Immediate-release: 5–15 mg PO/SL q4h prn. Concentrated liquid (20 mg/mL) is a hospice-standard sublingual option.
02Oxycodone 5–10 mg PO q4h prn is an alternative when morphine is not tolerated or when short duration is desired.
03Hydromorphone 1–2 mg PO or 0.2–0.4 mg IV/SC q4h prn for renal impairment or when morphine metabolites accumulate.
04Methadone is a valuable second-line strong opioid for neuropathic pain but requires QT/QTc awareness and slow titration; involve palliative-experienced physician for initiation.
05Fentanyl transdermal 12–25 mcg/hr q72h for stable, moderate–severe pain in a patient with predictable oral tolerance. Not for opioid-naïve patients.

Non-pharmacological approaches

Positioning and pressure-relief every 2 hours; consider air mattress for bedbound patients.
Heat/cold packs to affected areas (avoiding cold on ischemic limbs).
Guided-imagery, gentle massage, music therapy — validated adjuncts, not substitutes.
Family education: what to say to a patient in pain (avoid "you look great" if the patient is grimacing) and how to communicate a pain change to the on-call RN.

When to escalate

Uncontrolled pain > 24 hours despite two consecutive dose escalations.
Sudden onset of severe pain (may indicate fracture, obstruction, or clot).
New neurologic deficit accompanying pain (spinal cord compression is an emergency; consider dexamethasone + urgent evaluation).
Symptoms consistent with opioid-induced neurotoxicity: myoclonus, hyperalgesia, hallucinations, confusion — rotate to a different opioid at 50% of equianalgesic dose.

Documentation example

A composite narrative illustrating a defensible chart entry (identifying details fictionalized):

Patient reports 7/10 constant lumbar pain radiating to left leg. Now on morphine ER 30 mg PO q12h + morphine IR 10 mg PO q4h prn (using ~4 doses/day). Adding gabapentin 100 mg PO TID for the neuropathic component. Reassess in 24 hours; plan is to escalate morphine ER to 45 mg q12h if breakthrough use remains ≥3 doses/day. Patient and family verbalize understanding.

FAQ

Is morphine addictive in hospice patients?

The clinical concept of addiction (compulsive use despite harm) does not apply when opioids are used for hospice pain management. Physical dependence and tolerance are pharmacological and expected; they are not addiction.

How do we handle a patient who refuses opioids?

Respect the refusal, document, and pursue every non-pharmacological option plus adjuvant medications. Revisit gently as pain progresses. Involve the patient’s trusted family member if aligned with the patient’s wishes.

What if the patient can’t swallow?

Concentrated morphine sublingual is a hospice-standard route. For higher-need patients, consider subcutaneous morphine or hydromorphone or transdermal fentanyl (for stable pain only).

When do we consider methadone?

Methadone shines for neuropathic pain and mixed-mechanism pain when oral morphine equivalents exceed ~90–180 mg/day. Involve a palliative-experienced physician; conversion is not linear and requires close QTc monitoring during titration.

Grow every hospice competency, one symptom at a time.

Save this article to your team’s reading list and unlock deeper Goodwin Hospice Academy modules on hospice symptom management.

Create your free account Back to all symptoms

Hospice symptom management hub

What is HOPE?

What is IDG?

Sources

Educational content only. Not a substitute for your organization’s policies, your medical director’s clinical judgment, or current hospice formulary.